Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not exactly a 3D play... but consider that Oregano gets its organ creation material by refining and reproducing cells from a target donor.
Biotime (BTX) might be a perfect fit for Oregano to provide the basic cell samples. http://www.biotimeinc.com/video-series/
Natcore Technology Listed On Frankfurt Stock Exchange
Today : Wednesday 3 July 2013
RED BANK, N.J., July 3, 2013 /CNW/ - Natcore Technology Inc. (TSX-V: NXT; NTCXF.PK)has become listed on the Quotation Board of the Frankfurt Stock Exchange. The ticker symbol is 8NT. The market specialist is Baader Bank.
Owned and operated by Deutsche Borse AG, the Frankfurt Stock Exchange is the world's 10th largest stock exchange by market capitalization. Deutsche Borse also owns the European futures exchange Eurex and the clearing company Clearstream.
The Frankfurt Stock Exchange is located in Frankfurt, Germany. It accounts for over 90 percent of the turnover in the German market and a very large share of the European market. It facilitates advanced electronic trading, settlement and information systems, and so is able to meet the steadily growing requirements of cross-border trading.
Besides the specialist trading at Frankfurt Stock Exchange, its electronic trading system Xetra® is one of the leading electronic trading platforms in the world. More than 14 international exchanges have adopted Xetra. With its launch in 1997, the Frankfurt Stock Exchange has created attractive conditions for foreign investors and market participants. Some 130 of 250 market participants come from outside Germany.
Natcore's main listing remains on the TSX Venture Exchange. Quotes on the Frankfurt Exchange will be rendered in Euros.
"As we approach commercialization, we need a broader base for our shareholders," notes Natcore's CEO/President, Chuck Provini. "This move gives us exposure in a region where we have little penetration. We're having conversations with potential customers and joint venture partners in Europe. And we're pleased that a sixth market maker has asked to join our mix."
Before the addition of Baader Bank, Natcore had five market makers: Automated Trading Desk Financial Services; Canacord Genuity; Citadel Securities; G1 Execution Services; and Knight Execution & Clearing Services.
Statements in this press release other than purely historical factual information, including statements relating to revenues or profits, or Natcore's future plans and objectives, or expected sales, cash flows, and capital expenditures constitute forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in Natcore's business, including risks inherent in the technology history. There can be no assurance that such forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on such statements. Except in accordance with applicable securities laws, Natcore expressly disclaims any obligation to update any forward-looking statements or forward-looking statements that are incorporated by reference herein.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
Chuck Provini
732-576-8800
Info@NatcoreSolar.com
SOURCE Natcore Technology Inc.
Copyright 2013 Canada NewsWire
I agree. The upside here is tremendous. But to understand what they're doing takes more than an accountant's perception... which means that the market will not discover it until a major breakthrough occurs.
I suggest that anyone with an interest listens to the weekly videos they release. Fascinating stuff!!
http://www.biotimeinc.com/video-series/
Options appeared in my account.
My broker advises that I can exercise these options to receive an equal number of shares to those I already hold for $0.08 apiece. For each 2 shares purchased this way I also get one more option to buy 3 more shares at $0.08 later this year.
Taking these options averages my purchase price way down and seems like my only chance to break even or ... maybe... eventually... make some $$
No idea how many systems were sold so far in 2Q. But their sales force is in place ... worldwide. Somewhere I read that it is the same team employed by Intuitive Surgical (I can't verify this.) So buy a few shares and tighten your seat belt.
It just got listed on a US exchange. Up 'till now it was an Israeli stock.
Its business characteristics look a lot like Intuitive Surgical.
And investment advisers have begun to take notice:
http://www.streetauthority.com/value-investing/wall-street-noticing-these-micro-cap-stocks-heres-why-you-should-too-472365
IMO this one has only begun to run.
Any Americans holding MZRTF shares may want to consider asking their broker to convert these shares to the newly issued ADF ... MZOR.
Normally there would be a $0.05 per share conversion fee... but if you chose to convert in the next few weeks, the fee is waived.
Upon conversion, two shares of MZRTF become one share of MZOR.
My reasons for electing to convert are the increased volume in MZOR and the elimination of the $50 trade fee imposed when buying or selling "F" securities.
Good question. Usually the big guys with the supercomputers trade both sides to equal prices. Maybe they're not focused on Mazor yet. More likely, the MZTRF shares aren't really trading now because the Israeli market is closed.
We should be able to find out on Wednesday!
Q1 2013 Mazor Robotics Ltd. Earnings Conference Call
Wednesday, 29 May 8:30 am EDT
Investors within the United States interested in participating are invited to call 800-762-8779 and reference the Conference ID: 4621448. Participants in Israel can use the toll free dial-in number 1809-21-4368 and reference the same Conference ID number. All other international participants can use the dial-in number 480-629-9645, using the same Conference ID.
I believe Mazor sells the machines and then sells a "parts kit" for each operation the machines perform.
Lots of Companies developing surgical robots. But Intuitive and Mazor are the only two fully approved and available.
American Depositary Shares 5/28
CAESAREA, Israel, May 23, 2013 – Mazor Robotics Ltd. (TASE:MZOR), a developer of innovative surgical robots and complementary products, announced today that it will commence trading of its American Depositary Shares (ADSs) represented by American Depositary Receipts (ADRs) through The Bank of New York Mellon (“BNY Mellon”), on or about Tuesday May 28, 2013. Each ADS will represent 2 ordinary shares of the company and will trade on NASDAQ Capital Market under the trading symbol ‘MZOR.’ The company’s ordinary shares will continue to trade on the Tel Aviv Stock Exchange, under the trading symbol, ‘MZOR.’
Investors holding Mazor Robotics shares who are interested in converting their shares into the company’s ADSs should contact the company’s depositary bank, BNY Mellon:
New York
Melissa Sobolewski
Adrdesk@bnymellon.com
Tel: +1 212 815 2267
London
Damon Rowan
Damon.Rowan@bnymellon.com
Tel.: +44 207 163 7511
Hong Kong
Joseph Oakenfold
Joe.Oakenfold@bnymellon.com
Tel.: +852 2840 9717
It'll take a while... but someday the world will realize what this buncha Mensa'a are up to.
Then watch this stock fly.
President's Message
I think it was the 1970s when I first realized that it was no longer possible to buy a television set that was made in America.
As time went on, I began to notice other products that had suffered a similar fate: stereo equipment, digital cameras, and small appliances immediately come to mind. I’m sure you could add to the list.
And I realized this: Whoever owns the technology owns the industry.
We at Natcore are determined that the solar industry will not go the way of the transistor radio. For that reason, much of our time is spent in developing and protecting our solar technology. We are determined that the solar industry will be based on our home soil.
We’ll soon convene a series of meetings with our scientific brain trust, whom we believe are the greatest solar scientists in the world today. This distinguished cadre includes:
Dr. Dennis Flood, Natcore co-founder and Chief Technology Officer. A NASA veteran, with more than 30 years’ experience in developing solar cell and array technology for both space and terrestrial applications.
Dr. Andy Barron, Natcore co-founder. The Charles W. Duncan, Jr.-Welch Chair of Chemistry and Professor of Materials Science at Rice University, as well as a visiting Professor at the University of Wales.
Dr. David Levy, Natcore Director of Research & Technology. A Chemical Engineering PhD, with a minor in Electrical Engineering, from MIT, then 20 years as a research scientist at Eastman Kodak.
Dr. Daniele Margadonna, Chairman, Natcore advisory board. Chief Technology Officer of MX Group SpA in Villasanta, Italy. An international expert in the solar photovoltaic industry with extensive experience in the planning and construction of turnkey photovoltaic plants.
Dr. David Carlson, Natcore advisory board. Until his recent retirement, the chief scientist of BP Solar, for whom he managed future technology programs and the intellectual property system. He invented the amorphous silicon solar cell at RCA Laboratories
Our multitalented technicians—Ted Zubil, Rich Topel and Wendy Ahearn-- will participate, too. They’re an impressive bunch: they have 18 patents among them.
The meetings will be held at our Research and Development Center in Rochester, NY. Their purpose can be expressed in these questions: What are the strengths of our technology? What are the weaknesses? How can we maximize the strengths and fix the weaknesses? How can we most quickly move our technology from the lab to the production line?
Incidentally, we’ve finally consolidated all of our R&D work in Rochester. So there will be no more need for routine travel to university labs in Ohio, Arizona, and Texas. (Just to let you know how much money this will save us, we’re paying for Dr. Margadonna’s flight from Italy with airline miles accumulated from our past travel.)
In my next President’s message, I’ll report on the results of these meetings.
Sincerely,
Chuck Provini, President, CEO & Director
Ignore
AnythingIT Announces Continued Growth with New Tampa, Florida Facility
----
AnythingIT, Inc. Now Occupies More Than 77,000 Square Feet
Fair Lawn, NJ., May 9, 2013 – AnythingIT, Inc., (OTCBB: ANYI), a leading information technology electronics recycler and e-waste handler serving both government and commercial markets for over 20 years, announced today that its new 30,050 Square Foot Facility in Tampa, Florida is now fully operational. The facility first opened at the end of March, 2013 to process electronic waste, and perform both recycling and asset recovery to service new and existing customers.
David Bernstein, CEO stated, “The Tampa location will be able to recognize the immediate bottom-line benefits of our system-wide software implementation that allows for an automated and repeatable solution. The Tampa facility will follow the same certified standards as the Fair Lawn, NJ headquarters, ensuring that we remain at the highest levels of compliance with regulatory standards. We look forward to servicing both current and future valuable customers.”
AnythingIT is a US Government contractor holding small business certification as well as R2, e-Stewards, ISO 14001/9001, and Class D electronics recycling certifications. The company now occupies more than 77,000 square feet between the two locations.
About AnythingIT
AnythingIT is a leading asset management vendor and e-waste handler serving OEM's, Equipment Resellers, government and enterprise clients. Services provided by the company include: data scrubbing, shredding, inventory management, repair and remarketing of equipment and recycling of parts and materials. AnythingIT has been operating since 1992 and is a GSA Schedule Holder who has achieved R2 and ISO 14001 certification.
Safe Harbor Statement
The matters disclosed in this news release include forward looking statements. These statements represent the company's current judgment on the future and are subject to risk factors and uncertainties that could cause actual results to differ materially. To the extent that there are any statements that can be construed as forward looking, they should be considered in the context of all of our previous news releases and federal filings.
For information, please contact:
Gabrielle Bove
AnythingIT, Inc.
201-475-7301
gabrielleb@anythingit.com
or
Tony Schor, President
Investor Awareness, Inc.
847-945-2222 ext. 221
www.investorawareness.co
This business has high entry barrier requirements, both in terms of the logistics systems required and the technical skills of the employees.
ANYI may turn out to be a high reward long term holding for me.
AnythingIT Awarded 3 Year Contract With Lockheed Martin Corporation
GlobeNewswirePress Release: AnythingIT, Inc. – 1 minute 53 seconds ago
Email
Print
RELATED QUOTES
Symbol Price Change
LMT 102.88
FAIR LAWN, N.J., May 8, 2013 (GLOBE NEWSWIRE) -- AnythingIT, Inc., (ANYI), a leading information technology electronics recycler and e-waste handler serving both government and commercial markets, announces it has been awarded a 3 year nationwide contract to provide IT electronics recycling and remarketing services to Lockheed Martin Corporation (LMT).
AnythingIT is a US Government contractor holding a small business certification, as well as R2, e-Stewards, ISO 14001/9001, and a Class D electronics recycling certification in NJ.
According to CEO, David Bernstein, "We are excited and honored to have secured this contract to provide IT electronics recycling and remarketing services to Lockheed Martin Corporation (LMT). This contract reaffirms AnythingIT's leadership position as well as the effectiveness of our services to customers in managing their legacy IT equipment processes. We continue to focus on the disposition of assets in an environmentally compliant manner combined with providing market driven asset values for our customers. Furthermore, we are well positioned to be an effective solution to businesses and operators for years to come."
Services to be provided under the contract include, removal of IT equipment from client sites nationwide, detailed inventorying services, DoD data destruction services, remarketing, & recycling.
About AnythingIT
AnythingIT is a leading asset management vendor and e-waste handler serving OEM's, Equipment Resellers, government and enterprise clients. Services provided by the company include: data scrubbing, shredding, inventory management, repair and remarketing of equipment and recycling of parts and materials. AnythingIT has been operating since 1992 and is a GSA Schedule Holder who has achieved R2 and ISO 14001 certification.
Safe Harbor Statement
The matters disclosed in this news release include forward looking statements. These statements represent the company's current judgment on the future and are subject to risk factors and uncertainties that could cause actual results to differ materially. To the extent that there are any statements that can be construed as forward looking, they should be considered in the context of all of our previous news releases and federal filings.
Contact:
For information, please contact:
Gabrielle Bove
AnythingIT, Inc.
201-475-7301
gabrielleb@anythingit.com
or
Tony Schor, President
Investor Awareness, Inc.
847-945-2222 ext. 221
www.investorawareness.com
Mazor Robotics Receives Second Renaissance System Order from India Business Partner Advanced Medical Systems
BY Business Wire
— 4:00 AM ET 05/06/2013
CAESAREA, Israel--(BUSINESS WIRE)-- Mazor Robotics Ltd. (MZRTF
Loading... Loading...
) , a developer of innovative surgical robots and complementary products, today announced that Advanced Medical Systems PTE Ltd. (AMS), Mazor’s business partner in India, place an order for a Renaissance™ system. The system will be used in Nova Medical Centers at its Nova Orthopaedic & Spine Hospital, a newly-opened hospital in New Delhi to treat patients with spinal misalignments. This system marks the second Renaissance system in India following highly successful start at India’s largest hospital chain-Apollo Hospitals in Chennai.
Nova Medical Centers is the parent Company of Nova Specialty Surgery and Nova IVI Fertility. It currently has ten Specialty Surgery Centers and five In-Vitro Fertilization IVF Clinics. Nova Specialty Surgery develops, acquires, owns and operates short-stay surgical centers in partnership with surgeons across India and the Middle East (in partnership with the OMZEST group). Nova provides leading surgeons from diverse specialties with comprehensive ultra-modern facilities comprising doctor’s offices, operating rooms, pre and post operative rooms, diagnostics, imaging, health check-up area and a pathology laboratory. Nova’s innovative health services model offers unparalleled quality and affordability.
“This system represents Mazor’s second project in India, but given the high efficacy of Mazor’s Renaissance™ system and a desire by hospitals to provide its patients with the best procedural outcomes, I believe this sets out a much larger installed base,” expressed Romesh Kaul, President and Chief Executive Officer of AMS. “Dr. Harsha Hedge, one of India’s renowned and experienced orthopedic surgeons, will be using the system. With his well-earned reputation, he will lead the benefits of using Mazor’s Renaissance™ system in North India for the first time.”
“Nova Medical is one of India’s leading healthcare providers, working in partnership with doctors to ensure patients come first and that the most advanced services and technologies are employed for better patient outcomes,” stated Ori Hadomi, Mazor’s CEO. “By selecting to use our Renaissance™ system, Nova is maintaining this commitment and we are confident that our relationship with them will only strengthen going forward. Additionally, we are especially pleased to have a wonderful business partner in AMS which worked closely with Nova management to consider 2 projects starting with Delhi. Together Mazor & AMS will continue to identify new opportunities to advance our business objectives.”
Dr. Harsha Hegde has a rich experience of more than 20 years in the field of Joint Arthroplasty Surgeries, Spinal surgeries, and also in treating Trauma cases. He has not only gained expertise by training but also by treating thousands of patients every year. To his credit he has done more than 4000 joint replacement surgeries & around 2500 spine surgeries in the last ten years with high success rate. Today, he is considered as one of the most admired surgeons in this field in North India.
Renaissance, Mazor Robotics’ next generation surgical guidance system for spine procedures, is transforming spine surgery from freehand operations to highly-accurate, state-of-the-art procedures, with less radiation – even for minimally invasive surgery, scoliosis, and other complex spinal deformity cases. It is the only robotic technology for spine surgery available in the marketplace.
About Mazor
Mazor Robotics (MZRTF
Loading... Loading...
) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical robotic system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics (MZRTF
Loading... Loading...
) systems have been successfully used in the placement of over 35,000 implants in the United States and Europe. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics (MZRTF
Loading... Loading...
) technology. For more information, please visit www.mazorrobotics.com.
About Advanced Medical Systems
Founded in 1988, Advanced Medical Systems Pte Ltd (“AMS”) is an established medical devices organization offering innovative multi-disciplinary solutions for centers of excellence across the Asia Pacific region in Radiology, Neurosciences, Orthopedics & Oncology. It is the only organization of its kind to offer a complete range of services required for turnkey facility planning, technology implementation, training, management and finance. Headquartered in the Republic of Singapore, AMS directly serves the Asia/Pacific healthcare markets with operating bases and highly training personnel in Australia, Malaysia, Singapore and India for advanced imaging and minimally invasive therapy systems and services.
For more information visit Advanced Medical Systems at www.amssg.com or via Facebook at www.facebook.com/amssg.
Source: Mazor Robotics Ltd. (MZRTF)
Trading halt issued on 4/26 pending announcement by the company. Halt ends upon announcement or by 4/30.
Let's hope that this announcement benefits shareholders.
Venue Change
Mon, Apr 15, 2013 12:00 - Natcore Technology Inc . (NTCXF: OTC Link) - Venue Change - The symbol, NTCXF, no longer trades on Grey Market. As of Mon, Apr 15, 2013, NTCXF trades on OTC Link. You may find a complete list of venue changes at otcmarkets.com.
Natcore Makes Major Advancements In Black Silicon, Discovers Compelling New Application
Print
Alert
Natcore Technology . (GM) (USOTC:NTCXF)
Intraday Stock Chart
Today : Thursday 11 April 2013
Click Here for more Natcore Technology . (GM) Charts.
Black Silicon and Selective Emitter Have Been Prime Goals Of Solar Industry For Years
Solar Science Pioneer Joins Natcore's Advisory Board
RED BANK, N.J., April 11, 2013 /CNW/ - Natcore Technology Inc. (TSX-V: NXT; NTCXF.PK) has made major strides in advancing its black silicon solar cells to commercial levels of efficiency and, as part of its development process, has discovered that its technology could finally provide the industry with a low-cost selective emitter application.
Natcore's initial black silicon solar cells, the first full-size black silicon cells produced using a low-cost, scalable manufacturing process, had efficiencies of approximately 1%, as compared with average efficiencies for commercial cells of approximately 17%.
Through refinement of its in-lab production process, and despite the lack of a key piece of equipment, Natcore's technical staff has been able to achieve efficiencies as high as 14.7%.
These results have been achieved without an adequate diffusion furnace to control phosphorus diffusion into the solar cells' silicon surfaces. Natcore has now obtained and installed a fully capable diffusion furnace, with commissioning of this crucial piece of equipment having begun the week of April 1. The company's technical staff is confident that this diffusion furnace will allow for significant improvements in the efficiencies of its black silicon cells.
Importantly, Natcore's staff has discovered that its proprietary liquid phase deposition (LPD) may make a low-cost selective emitter application available to the solar industry. Selective emitter technology is a long-sought enhancement to solar cells in which the regions under a cell's front contacts are heavily doped to improve the electrical connection, while the remaining emitter surface is lightly doped to promote better efficiency.
Selective emitter applications have been proven to significantly increase solar cell efficiencies, but a low-cost, highly scalable process has remained elusive to industry. Theoretically, Natcore's LPD process could make this achievable, and early results from experiments using the company's newly installed diffusion furnace have been very encouraging.
Because of these positive results, Natcore is now rapidly moving to protect its selective emitter intellectual property, and is in the process of filing provisional patents.
"The solar industry has been clamoring for a selective emitter application that is cost-effective because of its demonstrated improvement to cell efficiencies," notes Natcore's CEO, Chuck Provini. "In fact, once Dr. Daniele Margadonna joined our Science Advisory Board and learned of our plans to install a new diffusion furnace, he immediately urged us to simultaneously pursue a selective emitter approach. I'm pleased to say that we were very quickly able to demonstrate the efficacy of our technology toward this crucial and valuable application."
Natcore's black silicon and selective emitter applications are not mutually exclusive; in fact, they are synergistic. Indeed, the envisioned production process would allow both of these important improvements to be seamlessly inserted into a solar cell manufacturing line.
"Combining Natcore's black silicon technology with our groundbreaking selective emitter technology could raise today's commercial solar cell efficiencies to new high levels, while still lowering the cost per watt," says Natcore's Chief Technology Officer, Dr. Dennis Flood. "Solar cell manufacturers are aggressively seeking easy-to-implement production steps that will improve their product and profitability without having to raise their prices. Natcore's combination of selective emitter and black silicon technologies promises to do just that."
Natcore also announced today that, after conducting due diligence into the company's technology, solar industry pioneer Dr. David Carlson has joined the company's Science Advisory Board.
A physicist with a worldwide reputation in photovoltaics and materials science, Dr. Carlson served as the chief scientist of BP Solar until his recent retirement.
In 1974, Dr. Carlson invented the amorphous silicon solar cell at RCA Laboratories, and was the first to demonstrate that hydrogenated amorphous silicon could be doped either p- or n-type and could be used to form a semiconductor junction.
Dr. Carlson was a co-recipient of the 1984 Morris N. Liebmann Award (IEEE) "for crucial contributions to the use of amorphous silicon in low-cost, high-performance photovoltaic solar cells." For his outstanding contributions in the field of solar energy, he has also received the Walton Clark Medal from the Franklin Institute, the William R. Cherry Award from the IEEE, and the Karl W. Boer Medal from the International Solar Energy Society and the University Delaware.
Dr. Carlson is a fellow of the IEEE and has been a member of the American Physical Society, the American Vacuum Society, and Sigma Xi. He has published more than 150 technical papers, has been issued 26 U.S. patents, and has eight patents pending. He is listed in Who's Who in America.
Dr. Carlson received a B.S. in Physics from Rensselaer Polytechnic Institute and a PhD in Physics from Rutgers University. He served as a U.S. Army captain in Pleiku, Vietnam in 1969 and 1970.
Dr. Carlson joins Dr. Daniele Margadonna, Chief Technology Officer of MX Group SpA, on Natcore's Science Advisory Board.
"These two scientists, along with our co-founders Dr. Andy Barron and Dr. Dennis Flood and our Director of Research, Dr. David Levy, give us a brain trust that in my opinion is unsurpassed in the solar industry," notes Brien Lundin, Natcore's Chairman. "Because of our recent advancements and expanding scientific and technical resources, we are also expanding our space at Eastman Business Park five-fold, to 20,000 square feet, in preparation for the progression of our technology from the lab to manufacturing facilities."
Statements in this press release other than purely historical factual information, including statements relating to revenues or profits, or Natcore's future plans and objectives, or expected sales, cash flows, and capital expenditures constitute forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in Natcore's business, including risks inherent in the technology history. There can be no assurance that such forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on such statements. Except in accordance with applicable securities laws, Natcore expressly disclaims any obligation to update any forward-looking statements or forward-looking statements that are incorporated by reference herein.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact: Chuck Provini
732-576-8800
Info@NatcoreSolar.com
SOURCE Natcore Technology Inc.
Copyright 2013 Canada NewsW
New study reports 98.9 percent implant accuracy when using Mazor Robotics Renaissance(TM) Guidance System for patients with significant spinal deformities
ORLANDO, Fla., March 12, 2013 /PRNewswire via COMTEX/ -- A study recently published in European Spine Journal concluded 98.9 percent accuracy when implanting pedicle screws using Mazor Robotics (TASE:MZOR) Renaissance(TM) Guidance System in a study group of 101 consecutive cases performed by Dr. Isador Lieberman of Texas Back Institute. 1 Ninety percent of the sample group had severe deformity and/or previous spine surgery that failed to correct the condition.
The clinical study stated, "In situations such as severe deformity or revision surgeries when the normal spinal anatomic landmarks have been altered or obscured, the robotic-guided system was especially useful to improve the accuracy in pedicle screw placement."
Historically, extreme curves and abnormalities of the spine with conditions such as scoliosis, can pose a significant challenge to surgeons when placing implants. Through virtual 3D planning software, Renaissance eliminates some of the difficulty and helps the surgeon obtain greater accuracy by guiding to the exact trajectories planned (watch "How it Works").
Nine hundred and forty nine implants were accurately placed and 11 implants were not initially placed in the ideal position, presumably due to "tool skiving" off the facet or transverse process.
To date, Mazor Robotics technology has been used worldwide in thousands of cases, including more than 500 complex spine deformity and revision procedures.
Percutaneous and minimally-invasive (MIS) approaches were used in 25.3 percent of the surgeries in this study, exemplifying the applicability of Renaissance for MIS in the most complex spine surgeries. The authors noted, "The diverse patient population demonstrated the broad utility of this robotic-assisted system in challenging spine surgeries."
Additional peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology. For more information, visit www.MazorRobotics.com.
About MazorMazor Robotics is dedicated to the development of innovative surgical guidance systems and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics' systems have been successfully used in the placement of tens of thousands of implants in the United States and Europe.
1. Hu, X, Ohnmeiss D. Lieberman,I. Robotic-assisted pedicle screw placement: lessons learned from the first 102 patients. Eur Spine J (2013) 22:661-666.
Contact: Stephani NewmanMarketing Communications ManagerMazor Robotics, Inc.S.Newman@MazorRobotics-US.com 1 (800) 80 - MAZOR
SOURCE Mazor Robotics
http://rt.prnewswire.com/rt.gif?NewsItemId=NY74951&Transmission_Id=201303120900PR_NEWS_USPR_____NY74951&DateId=20130312
www.prnewswire.com
June 11, 2012 04:00 AM Eastern Daylight Time
Mazor Robotics Announces First Brain Cases Using Its Robotic Platform
Mazor expands clinically validated technology from spine into guided brain operations
CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd. (TASE: MZOR), a developer of innovative surgical robots and complementary products, today announced the successful completion of the first robot-guided brain surgical procedures, which were performed with Mazor Robotics’ technology. Neurosurgeons Dr. In-Se Kim and Prof. Robert Schönmayr performed the first three cases at HSK Hospital, (Horst Schmidt Kliniken GmbH) in Wiesbaden, Germany.
“As one of the first medical centers globally to adopt robotic technology for spine surgeries, we are very proud to also be the first to expand its use to brain surgeries”
“As one of the first medical centers globally to adopt robotic technology for spine surgeries, we are very proud to also be the first to expand its use to brain surgeries,” said Prof. Schönmayr.
“We see great potential in the application of robotic technology to brain and spine surgeries. Our patients have been the best testament to its clinical success,” added Dr. Kim.
In addition to its proven applications in spine surgeries, Mazor Robotics’ technology is applicable in the brain for biopsies, shunt placements and neurostimulation electrode placement such as for deep brain stimulation (DBS). As a frameless treatment solution for brain procedures, the robot’s precision, simplicity and safety profile have the potential to increase patient comfort, improve surgical accuracy and provide a less invasive approach, as well as potentially increase utilization of the installed base.
There are about 25,000 brain biopsies in the United States each year. The DBS placement market is estimated to be several hundred million dollars annually.
“While our core is spine surgery, we are thrilled that our technology can be expanded to improve other surgical procedures,” said Ori Hadomi, CEO of Mazor Robotics. “Brain surgeries represent a large market opportunity that is aligned with our current focus on spine. Approximately half of surgeons who currently use Mazor’s Renaissance and SpineAssist robots for spinal surgeries are neurosurgeons, the call point for brain surgery. By offering a spine surgery and brain surgery solution, we provide a solution for a greater number of physicians in the typical neurosurgery department.”
Regulatory clearance for the brain application is pending in the U.S. and Europe. Upon regulatory clearance, the brain application will be available as an add-on to Mazor’s Renaissance system at a separate price point expected early 2013.
About Mazor Robotics
Mazor Robotics Ltd (TASE: MZOR) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical guidance system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 20,000 implants in the United States and Europe. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology. For more information, visit www.mazorrobotics.com.
Contacts
U.S.:
EVC Group
Greg Gin/Doug Sherk, 646-445-4801 (Investors)
ggin@evcgroup.com / dsherk@evcgroup.com
Steve DiMattia, 646-201-5445 (Media)
sdimattia@evcgroup.com
This little-known company is amazing. Here's a quote from an investment service called "Game Changing Stocks" a few months ago:
"Even better: to date Mazor robots have a 100% safety record. In no documented case have they caused permanent nerve damage. That is particularly impressive given that the company's case volume has grown by more than 500% in the past four quarters alone! Right now, this tiny company only has a user base of 39 units. But this is a system that hundreds of hospitals in the United States, which accounts for 75% of Mazor's revenue, could use. The company is also developing an international sales footprint. And here's the kicker: Its sales team was recruited from Intuitive Surgical. These guys have already convinced hundreds of hospitals to buy. Now they have a new product. I can't get enough of this stock."
Just looked at last year's financials. On 12/31/2012 there were only 24,011,000 shares outstanding!!
Anybody else even looking at Mazor? It's lonely on this board.
Just broke $5. Now the big funds can play. How long 'till $10? My guess, one week.
Mazor Robotics: Pact Brings Total Number Of Renaissance Installations In Clinical Institutions In U.S. To 26, And Globally To 48
Unknown – 8:55 AM ET 04/02/2013
Mazor Robotics Signs Agreement with Major U.S. Hospital Corporation to Acquire Four Renaissance Systems
BY Business Wire
— 8:54 AM ET 04/02/2013
CAESAREA, Israel--(BUSINESS WIRE)-- Mazor Robotics Ltd. (MZRTF
Loading... Loading...
) , the developer of Renaissance™, an innovative surgical guidance system and its complementary products, today announced that on March 28, 2013, it entered into an agreement for the acquisition of four Renaissance systems by a major U.S. hospital corporation. The systems were installed in acute-care facilities owned by the corporation in four separate U.S. markets.
“This agreement marks a significant, strategic achievement for Mazor,” said Ori Hadomi, Chief Executive Officer of Mazor Robotics (MZRTF
Loading... Loading...
). “These first four installations will serve as the platform for Renaissance within four of our customer’s markets, and we look forward to seeing their patients and staff benefiting from the clinical value of our technology.”
Renaissance, Mazor Robotics’ state-of-the-art surgical guidance system for spine procedures, is transforming spine surgery from freehand operations to highly-accurate, planned procedures, with less intra-operative radiation – even for minimally invasive surgery, scoliosis, and other complex spinal reconstructive surgeries.
The agreement announced today brings the total number of Renaissance installations in clinical institutions in the USA to 26, and globally to 48.
About Mazor
Mazor Robotics (MZRTF
Loading... Loading...
) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical robotic system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics (MZRTF
Loading... Loading...
) systems have been successfully used in the placement of over 35,000 implants in the United States, Asia, and Europe. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics (MZRTF
Loading... Loading...
) technology. For more information, please visit www.mazorrobotics.com.
Source: Mazor Robotics Ltd. (MZRTF)
At $5 the larger funds can start to buy. MZRTF has been going up like a rocket. Will it hit $5 today, or do we have to wait until next week?
Mazor Robotics Receives First Renaissance System Order From Taiwanese Distribution Partner
BY Business Wire
— 4:00 AM ET 03/28/2013
CAESAREA, Israel--(BUSINESS WIRE)-- Mazor Robotics Ltd. (MZRTF
Loading... Loading...
) , the developer of Renaissance™, an innovative surgical guidance system and its complementary products, today announced that Pinnaclemed Co., Ltd., the Company’s distribution partner in Taiwan, purchased its first Renaissance system. The system will be installed during the second quarter in a leading institution in Taiwan.
In January Mazor received regulatory approval to market its Renaissance technology in Taiwan. The Company is marketing Renaissance throughout the Asia Pacific region and currently has systems installed in several countries, including Japan, China, Korea, India, Singapore, Vietnam, and Australia.
“As a company recognized for bringing innovation to the Taiwan market, we are pleased to partner with Mazor, who has helped pioneer this technology and its application to spinal surgery,” said Audy Chao, Chief Executive Officer of Pinnaclemed. “With the minimally invasive spine (MIS) market growing annually, we look forward to working closely with Mazor to bring the benefits of robotic MIS surgery to surgeons and patients across Taiwan.”
“I’m pleased to announce the purchase of the first Renaissance system in Taiwan,” stated Ori Hadomi, Chief Executive Officer of Mazor. “We have made great progress in Taiwan through our partnership with Pinnaclemed, and we expect Taiwan to offer strong growth prospects for Renaissance in the coming years. We are excited to bring our innovative technology to the Taiwanese surgeons and patients.”
Renaissance, Mazor Robotics’ next generation surgical guidance system for spine procedures, is transforming spine surgery from freehand operations to highly-accurate, state-of-the-art procedures, with less intra-operative radiation – even for minimally invasive surgery, scoliosis, and other complex spinal deformity cases. It is the only robotic technology for spine surgery available in the marketplace.
About Mazor
Mazor Robotics (MZRTF
Loading... Loading...
) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical robotic system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics (MZRTF
Loading... Loading...
) systems have been successfully used in the placement of over 35,000 implants in the United States, Europe, and Asia. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics (MZRTF
Loading... Loading...
) technology. For more information, please visit www.mazorrobotics.com.
Source: Mazor Robotics Ltd. (MZRTF)
Baptist Medical Center Jacksonville Acquires Mazor Robotics’ Renaissance System
BY Business Wire
— 6:00 AM ET 03/21/2013
CAESAREA, Israel--(BUSINESS WIRE)-- Mazor Robotics Ltd. (MZRTF
Loading... Loading...
), the developer of Renaissance™, an innovative surgical guidance system and its complementary products, today announced that Baptist Medical Center Jacksonville in Florida acquired its first Renaissance system. Baptist Health neurosurgeon Andrew Cannestra, MD, will perform the first surgery with the new device.
Baptist Medical Center Jacksonville is a community hospital and the central hub of Baptist Health, a five-hospital, 1,100-bed health system in Northeast Florida. Baptist Health has been recognized for its use of the latest medical technologies.
“This technology makes Baptist Jacksonville a true robotic center, adding Renaissance to the da Vinci and MAKO systems our physicians are currently using for minimally invasive procedures,” said Michael Mayo, FACHE, Hospital President of Baptist Medical Center Jacksonville. “Renaissance allows us to expand our tertiary level capabilities to care for the most complex spinal surgery patients in the region, ultimately enhancing quality outcomes.”
“The arrival of the Renaissance system will allow new program development in spinal surgery in the Jacksonville area and further advance minimally-invasive spinal surgery in the Baptist Health system,” Dr. Cannestra said. “This robotic spinal surgery solution allows us to treat more complex spinal deformity patients, those who have severe scoliosis, with less radiation, less operative time and less blood loss.”
“We’re so pleased to introduce Renaissance to the neurosurgery and orthopaedic spine surgeons at Baptist Medical Center Jacksonville. The hospital is known for coupling highly advanced diagnostic and treatment capabilities with personalized care, and I’m thrilled to offer our technology to the surgeons and patients of another outstanding facility in Florida,” stated Ori Hadomi, Chief Executive Officer of Mazor.
Renaissance, Mazor Robotics’ next generation surgical guidance system for spine procedures, is transforming spine surgery from freehand operations to highly-accurate, state-of-the-art procedures, with less radiation – even for minimally invasive surgery, scoliosis and other complex spinal deformity cases. It is the only robotic technology for spine surgery available in the marketplace.
About Mazor
Mazor Robotics (MZRTF
Loading... Loading...
) is dedicated to the development and marketing of innovative surgical guidance system and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical guidance system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics (MZRTF
Loading... Loading...
) systems have been successfully used in the placement of over 20,000 implants in the United States and Europe. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics (MZRTF
Loading... Loading...
) technology. For more information, please visit www.mazorrobotics.com.
Source: Mazor Robotics Ltd. (MZRTF)
Houston’s Westside Surgical Hospital Acquires Mazor Robotics’ Renaissance System
BY Business Wire
— 3:07 PM ET 03/26/2013
CAESAREA, Israel--(BUSINESS WIRE)-- Mazor Robotics Ltd. (MZRTF
Loading... Loading...
) , a developer of innovative surgical robots and complementary products, today announced that Westside Surgical Hospital in Houston, Texas acquired its Renaissance™ system. The system will be used by the hospital’s renowned spinal surgeons, including Richard R.M. Francis, MD. This system marks the 7th Renaissance system in Texas and the 21st system in the U.S.
Westside Surgical Hospital is a multi-specialty physician-owned hospital located in the heart of Houston. The facility employs a wide suite of physicians to service patients and counts spine surgery as one of its primary specialties. Dr. Richard Francis has special expertise in spinal disc replacement surgery, scoliosis correction, and revision/reconstruction of the previously operated spine. He practices spinal medicine exclusively. In 2012, he was recognized by Mazor for successfully performing over 100 Renaissance Robotics spine surgeries.
”When I first saw the Renaissance at NASS 2011, I was immediately impressed,” said Dr. Francis. “After my due diligence, I am convinced that the Renaissance system’s exceptional accuracy and safety will enhance outcomes for my patients, particularly those with advanced deformities and severe scoliosis.”
“We are so pleased to be supplying a system to Westside Surgical Hospital - an advocate of the Renaissance technology in the Houston marketplace,” stated Ori Hadomi, Mazor’s CEO. “We expect the system to be used in at least eight cases during its initial installation period of two weeks. As a leading authority in spine medicine, we’re thrilled to work with Dr. Francis again, this time bringing Renaissance to the patients of Westside Surgical Hospital.”
“By partnering closely with the leaders of spinal robotic technology, we are equipping our surgeons with the right tools to provide the best possible outcomes,” shared Westside Surgical Hospital’s Board Chairman, Mustapha Kibirige, MD. “This investment is part of our promise to offer the safest and most accurate surgical solutions for our patients.”
Renaissance, Mazor Robotics’ next generation surgical guidance system for spine procedures, is transforming spine surgery from freehand operations to highly-accurate, state-of-the-art procedures, with less radiation – even for minimally invasive surgery, scoliosis, and other complex spinal deformity cases. It is the only robotic technology for spine surgery available in the marketplace.
About Mazor
Mazor Robotics (MZRTF
Loading... Loading...
) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical robotic system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics (MZRTF) systems have been successfully used in the placement of over 35,000 implants in the United States and Europe. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics (MZRTF) technology. For more information, please visit www.mazorrobotics.com.
Source: Mazor Robotics Ltd. (MZRTF)
A question for you about ANYI vs EWSI.
From simply looking at their respective sites, I observe that ANYI has a highly competent technically astute group of personnel.
EWSI seems to recognize the long term opportunity in reverse logistics... but their expertise seems to be more in corporate acquisition and expansion.
Comments?
Very reassuring to hear that from you. The only thing that held me back from taking a large position here was the very low share price. But when they retained Investor Awareness I became more confident about them and began picking up a nice batch of cheapies.
Mazor Robotics Receives First Renaissance System Order from Australian Distribution Partner LifeHealthcare
CAESAREA, Israel – March 10, 2013 – Mazor Robotics Ltd. (TASE: MZOR), the developer of Renaissance™, an innovative surgical guidance system and its complementary products, today announced that LifeHealthcare, the Company’s distribution and marketing partner in Australia, has ordered its first Renaissance system. The system will be used for training, marketing, and sales purposes, as the distributor’s sales force penetrates the Australian market. Mazor recently announced on March 3, 2013 that its Renaissance technology received regulatory approval in Australia.
LifeHealthcare is a leading medical devices distributor in Australia and is marketing and distributing the Renaissance technology in the country on behalf of Mazor. The Australian and New Zealand spine market represents a growing market as surgeons and patients seek innovative technology to enhance surgical capabilities and enrich patient care.
“We are very pleased to work with LifeHealthcare to bring Renaissance to Australia,” said Ori Hadomi, CEO of Mazor. “The system sold marks the first Renaissance to be installed in the region and will be used to demonstrate the value it can bring, helping to increase surgeon accuracy and improve patient outcomes. We look forward to introducing more systems to the Australian spinal surgery community as surgeons become accustomed with the technology and its benefits.”
Renaissance, Mazor Robotics’ next generation surgical guidance system for spine procedures, is transforming spine surgery from freehand operations to highly-accurate, state-of-the-art procedures, with less radiation – even for minimally invasive surgery, scoliosis, and other complex spinal deformity cases. It is the only robotic technology for spine surgery available in the marketplace.
About Mazor
Mazor Robotics (TASE:MZOR) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical robotic system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 20,000 implants in the United States and Europe. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology. For more information, please visit www.mazorrobotics.com.
U.S. Contacts:
Investors
Aimee Gordon/Robert Jones
EVC Group
646-445-4800
agordon@evcgroup.com/ bjones@evcgroup.com
Media
Chris Gale
EVC Group
646-201-5431
That may be good advice. The following is from their latest 10Q:
"In fiscal 2013 we expect to expand into geographical areas where we have an existing customer base to expand our footprint and our business presence. During the third quarter of fiscal 2013 we will open a processing facility in Tampa, Florida. The Tampa facility will mirror the capabilities that we currently have in New Jersey. Our decision to expand in the Tampa market was based in part upon an informal request from one of our largest customers who has a large presence in that market. The location of a second facility in the Tampa area will permit us to process the equipment the customer has in the local market that they do not send up to our New Jersey facility, which we expect to result in increased sales. We expect to fund those incremental costs from working capital. We also expect to seek to acquire additional companies whose operations are complementary to ours, including companies with similar business models located in different geographical areas, and companies that offer different services, such as demanufacturers. Based upon our internal analysis of our industry and our competitors, we believe that there are a number of potential target companies, but there are no assurances our beliefs are correct or that we will ever close any acquisitions."
Please clarify your post for a normally silent investor with quite a few shares of WAFR. Who is Elie Kauderer?
I started paying attention when they retained Investor Awareness. Now let's see a few progress announcements or a buyout.
Fujitsu Partners with AnythingIT to Offer New Trade-in Program
Fujitsu is now offering a value for Lifebook T Series computers
March 14, 2013
Fujitsu Corporation has partnered with AnythingIT to offer an exciting new trade-in program that rewards returning customers with a Trade in value on their existing LIFEBOOK T Series.
For a limited time only, Fujitsu customers can get a trade-in value ranging from $65-95 per unit when trading in their Lifebook T Series towards the purchae of a new Lifebook T732 or T902 Tablet.